Tenaya Therapeutics, Inc. Increase (Decrease) in Contract with Customer, Liability
Tenaya Therapeutics, Inc. (TNYA) reported Increase (Decrease) in Contract with Customer, Liability of $9.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-05
- Tenaya Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$739.00K.
- Tenaya Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was $10.40M.
- Tenaya Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was $0.00.
- Tenaya Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-03-31 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month |
|---|---|---|
| 2026-06-30 | -$739.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $9.66M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $10.40M 10-Q · filed 2026-05-06 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |